Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Nektar Therapeutics

    NASDAQ: NKTR · Real-Time Price · USD
    8.56
    -0.20 (-2.28%)
    At close: Jun 13, 2025, 3:59 PM
    8.70
    1.58%
    After-hours: Jun 13, 2025, 07:18 PM EDT

    Nektar Therapeutics Statistics

    Share Statistics

    Nektar Therapeutics has 12.41M shares outstanding. The number of shares has increased by 0.23% in one year.

    Shares Outstanding

    n/a
    		 12.41M

    Shares Change (YoY)

    n/a
    		 0.23%

    Shares Change (QoQ)

    n/a
    		 -0.01%

    Owned by Institutions (%)

    n/a
    		 63.51%

    Shares Floating

    n/a
    		 11.96M

    Failed to Deliver (FTD) Shares

    n/a
    		 5,389

    FTD / Avg. Volume

    n/a
    		 2.89%

    Short Selling Information

    The latest short interest is 11.3M, so 91.12% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 11.3M

    Short % of Shares Out

    n/a
    		 91.12%

    Short % of Float

    n/a
    		 93.86%

    Short Ratio (days to cover)

    n/a
    		 7.32

    Valuation Ratios

    The PE ratio is -1.61 and the forward PE ratio is -0.73. Nektar Therapeutics's PEG ratio is 0.03.

    PE Ratio

    n/a
    		 -1.61

    Forward PE

    n/a
    		 -0.73

    PS Ratio

    n/a
    		 1.94

    Forward PS

    n/a
    		 1

    PB Ratio

    n/a
    		 3.15

    P/FCF Ratio

    n/a
    		 -1.08

    PEG Ratio

    n/a
    		 0.03
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Nektar Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.26, with a Debt / Equity ratio of 1.69.

    Current Ratio

    n/a
    		 4.26

    Quick Ratio

    n/a
    		 4.26

    Debt / Equity

    n/a
    		 1.69

    Debt / EBITDA

    n/a
    		 -1.18

    Debt / FCF

    n/a
    		 -0.58

    Interest Coverage

    n/a
    		 -3.74

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $1,613,557.38

    Profits Per Employee

    n/a
    		 $-1,950,180.33

    Employee Count

    n/a
    		 61

    Asset Turnover

    n/a
    		 0.32

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -239K

    Effective Tax Rate

    n/a
    		 0.2%

    Stock Price Statistics

    The stock price has increased by -51.23% in the last 52 weeks. The beta is 0.56, so Nektar Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.56

    52-Week Price Change

    n/a
    		 -51.23%

    50-Day Moving Average

    n/a
    		 9.54

    200-Day Moving Average

    n/a
    		 14.26

    Relative Strength Index (RSI)

    n/a
    		 43.86

    Average Volume (20 Days)

    n/a
    		 186,660

    Income Statement

    In the last 12 months, Nektar Therapeutics had revenue of 98.43M and earned -118.96M in profits. Earnings per share was -0.58.

    Revenue

    n/a
    		 98.43M

    Gross Profit

    n/a
    		 67.74M

    Operating Income

    n/a
    		 -105.2M

    Net Income

    n/a
    		 -118.96M

    EBITDA

    n/a
    		 -86.7M

    EBIT

    n/a
    		 -91.09M

    Earnings Per Share (EPS)

    n/a
    		 -0.58
    Full Income Statement

    Balance Sheet

    The company has 44.25M in cash and 102.56M in debt, giving a net cash position of -58.31M.

    Cash & Cash Equivalents

    n/a
    		 44.25M

    Total Debt

    n/a
    		 102.56M

    Net Cash

    n/a
    		 -58.31M

    Retained Earnings

    n/a
    		 -3.6B

    Total Assets

    n/a
    		 256.24M

    Working Capital

    n/a
    		 158.98M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -175.71M and capital expenditures -1.47M, giving a free cash flow of -177.18M.

    Operating Cash Flow

    n/a
    		 -175.71M

    Capital Expenditures

    n/a
    		 -1.47M

    Free Cash Flow

    n/a
    		 -177.18M

    FCF Per Share

    n/a
    		 -0.86
    Full Cash Flow Statement

    Margins

    Gross margin is 68.82%, with operating and profit margins of -106.88% and -120.86%.

    Gross Margin

    n/a
    		 68.82%

    Operating Margin

    n/a
    		 -106.88%

    Pretax Margin

    n/a
    		 -121.1%

    Profit Margin

    n/a
    		 -120.86%

    EBITDA Margin

    n/a
    		 -88.08%

    EBIT Margin

    n/a
    		 -106.88%

    FCF Margin

    n/a
    		 -180.01%

    Dividends & Yields

    NKTR does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for NKTR is $75, which is 776.2% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $75

    Price Target Difference

    n/a
    		 776.2%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 6
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jun 9, 2025. It was a backward split with a ratio of 1:15.

    Last Split Date

    n/a
    		 Jun 9, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:15

    Scores

    Altman Z-Score

    n/a
    		 -19.82

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist